BRCA2 and cancer: Human studies suggest that elevated PRA expression is generally associated with a poor prognosis, and there is evidence that genetic predisposition to cancer development due to mutations in BRCA1 or BRCA2 genes leads to PRA overexpression, which may play a role in disease progression [16,17].